Bank Of New York Mellon Corp Xeris Biopharma Holdings, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.14 - $1.65 $468,318 - $677,829
410,806 New
410,806 $546,000
Q3 2022

Nov 14, 2022
BUY
$1.37 - $1.93 $48,103 - $67,766
35,112 Added 9.34%
411,113 $642,000
Q2 2022

Aug 15, 2022
BUY
$1.48 - $2.64 $414,593 - $739,545
280,131 Added 292.2%
376,001 $579,000
Q4 2021

Feb 11, 2022
BUY
$1.8 - $2.93 $172,566 - $280,899
95,870 New
95,870 $281,000

Others Institutions Holding XERS

# of Institutions
144
Shares Held
60.1M
Call Options Held
148K
Put Options Held
45.7K
View Full List

About Xeris Biopharma Holdings, Inc.

XERS Quotes by TradingView
  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $479M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email